Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

During the Trading Day
39.13 -0.21 / -0.53%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
39.19 +0.058 / +0.15%
 
Volume: 3.0K

Today’s Trading

Previous close39.34
Today’s open39.31
Day’s range39.05 - 39.65
Volume5,805,388
Average volume (3 months)3,823,445
Market cap$95.8B
Dividend yield6.09%
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-22.80%
Earnings growth (next 5 years)+4.10%
Revenue growth (last year)-8.75%
P/E ratio9.7
Price/Sales2.74
Price/Book14.39

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+1.33+2.86%
SNYSanofi-0.38-0.98%
BMYBristol-Myers Squibb+0.06+0.10%
ABBVAbbVie-0.76-1.42%
Data as of 4:02pm ET, 02/10/2016

Financials

Next reporting dateApril 27, 2016
EPS forecast (this quarter)$0.55
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers